G2MC 8th International Conference

G2MC 8th International Conference

March 31 – April 3 | Colombo, Sri Lanka

The Global Genomic Medicine Consortium (G2MC) 8th International Conference themed “Collaboration Beyond Borders for Global Implementation of Genomic Medicine” will be held in Colombo, Sri Lanka, for a combined 4-day workshop/conference hosted by the University of Colombo.

The conference takes place at a pivotal time, as genomic medicine transitions from research discoveries to clinical applications with the potential to significantly improve health outcomes. However, the pace of integrating these advancements into healthcare systems varies considerably across the globe.

To learn more, visit the conference webpage. Registration information coming soon. Please note: Registration is required.

Carolina Seminar Series | Ensuring Fairness: At the Crossroads of Equity and Economic Considerations in Precision Medicine

Ensuring Fairness: At the Crossroads of Equity and Economic Considerations in Precision Medicine

Tuesday, March 26 | 12 p.m. ET | Virtual

Speaker: Kate Saylor, PhD
Fellow, Ethical, Legal, and Social Implications (ELSI) of Genetics and Genomics,
Perelman School of Medicine at the University of Pennsylvania

Efforts to expand access to genomic health and precision medicine have resulted in a proliferation of screening programs for healthy adult populations across the nation. Issues of fairness and equity abound in medicine and are a critical component of assessing implementation of these genomic health and precision medicine efforts. But how can programs such as genomic screening ensure equitable access within a healthcare system that is already characterized by massive health disparities and barriers to equitable access? When and how should cost-effectiveness be considered when designing screening programs and their offerings? How can cost-effectiveness models incorporate justice, equity and inclusion? In this seminar session, we will explore these questions and the overall relationship between equity and economic considerations in precision medicine.

To learn more and register, visit the event webpage.

Personalized Risk Assessment for Early Detection of Cancer

Personalized Risk Assessment for Early Detection of Cancer

Thursday, December 21 | 9 a.m. ET | Online

Speaker: Dr. Nora Pashayan

Dr. Pashayan is a Professor of the Epidemiology of Aging and honorary Consultant in Public Health Medicine at the University of Cambridge.  She is a cancer epidemiologist, a clinician with specialties in both Family Medicine and Public Health Medicine, and the Director of Training for the International Alliance for Cancer Early Detection. Dr. Pashayan’s primary research field is cancer early detection, risk stratification, and population-level screening.  Her research focuses on understanding disease courses, evaluating screening strategies, and implementation of novel screening strategies.

This talk will introduce the concept of risk-stratified cancer screening and explore the essential considerations for implementation of such a screening program. Examples on integration and implementation will be drawn from the ongoing Canadian study, PERSPECTIVE I&I.

To learn more and register, visit the GGMC Educational Webinar Series page.

Please note: Registration is required for this webinar.